COLL Form 144: Notice to Sell 49,976 Shares

COLL filed a Form 144 reporting a proposed sale of 49,976 common shares tied to restricted stock vesting on 02/10/2026.

Accepted by SEC EDGAR 03/03/2026 - 04:10 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

COLL filed a Form 144 reporting a proposed sale of 49,976 common shares tied to restricted stock vesting on 02/10/2026. The filing also records a prior disposition of 17,600 common shares by Scott Dreyer on 12/08/2025 for $847,855.36. The form lists 31,753,211 shares outstanding as of 03/03/2026.

Insights

Securities Compliance Counsel

Form 144 notifies the market of an intended resale of restricted shares.

The filing lists a proposed sale of 49,976 common shares associated with restricted stock vesting dated 02/10/2026. This is a notice of a planned resale under resale rules and does not itself effect a transfer.

Cash‑flow treatment and execution timing are not provided; the earlier sale by Scott Dreyer of 17,600 shares on 12/08/2025 for $847,855.36 is recorded as a past disposition. Subsequent filings will show whether and how the proposed shares are sold.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does COLL's Form 144 report?

The Form 144 reports a proposed sale of 49,976 common shares tied to restricted stock vesting on 02/10/2026. It notifies the SEC and market of an intended resale under resale rules rather than completing a sale.

Who previously sold shares according to the filing for COLL?

Scott Dreyer is shown as having sold 17,600 common shares on 12/08/2025 for $847,855.36. That transaction is listed under securities sold during the past three months.

How many COLL shares are outstanding per the filing?

The filing lists 31,753,211 shares outstanding as of 03/03/2026. This figure is presented as an outstanding-share count in the provided excerpt.

Does the Form 144 confirm the sale of the 49,976 COLL shares?

No; the Form 144 notifies an intended resale of 49,976 shares tied to vesting on 02/10/2026. Actual sale execution and proceeds are not recorded in this notice.

Who is the broker or intermediary named in the filing for COLL shares?

The excerpt names Fidelity Brokerage Services LLC with an address at 900 Salem Street, Smithfield, RI; it is listed in the securities information row associated with the 49,976 shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001746251
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	COLLEGIUM PHARMACEUTICAL, INC
SEC File Number	001-37372
Address of Issuer	100 TECHNOLOGY CENTER DRIVE STOUGHTON MASSACHUSETTS 02072
Phone	781-713-3699
Name of Person for Whose Account the Securities are To Be Sold	Dreyer Scott
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	49976	2019439.23	31753211	03/03/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/10/2026	Restricted Stock Vesting	Issuer			49976	02/10/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Scott Dreyer 100 Technology Center Drive Stoughton MA 02072	Common	12/08/2025	17600	847855.36

144: Remarks and Signature

Remarks
Date of Notice	03/03/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	09/03/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Joshua Schmitt, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Scott Dreyer.
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)